Authorship: WBM collected and analyzed data and wrote the manuscript, JJ
collected data, JD collected data and revised the manuscript, AT
collected data and revised the manuscript, KAM revised the manuscript,
EJS performed statistical analyses, SOB analyzed data and revised the
manuscript, DM oversaw data collection, analyzed data and revised the
manuscript
Conflict of interest statement: The authors declare no competing
financial conflicts.
References
1. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. May 4 2020:1-10. doi:10.1007/s00134-020-06062-x
2. Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of Coronavirus Disease 2019. Crit Care Med. May 27 2020;doi:10.1097/ccm.0000000000004458
3. Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. Sep 2020;18(9):2103-2109. doi:10.1111/jth.14975
4. Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res. Dec 2020;69(12):1181-1189. doi:10.1007/s00011-020-01401-6
5. Castagnoli R, Votto M, Licari A, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatrics. 2020;doi:10.1001/jamapediatrics.2020.1467
6. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 06 2020;145(6)doi:10.1542/peds.2020-0702
7. Du H, Dong X, Zhang JJ, et al. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy. Jun 2020;doi:10.1111/all.14452
8. Romani L, Chiurchiù S, Santilli V, et al. COVID-19 in Italian pediatric patients: the experience of a tertiary children's hospital. Acta Paediatr. Jul 2020;doi:10.1111/apa.15465
9. Jiang L, Tang K, Levin M, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. Nov 2020;20(11):e276-e288. doi:10.1016/s1473-3099(20)30651-4
10. Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr. Sep 1 2020;174(9):868-873. doi:10.1001/jamapediatrics.2020.1948
11. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. Aug 2020;20(8):e192-e197. doi:10.1016/s1473-3099(20)30483-7
12. Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. Feb 2012;141(2 Suppl):e737S-e801S. doi:10.1378/chest.11-2308
13. Wang TF, Milligan PE, Wong CA, Deal EN, Thoelke MS, Gage BF. Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemost. Jan 2014;111(1):88-93. doi:10.1160/th13-01-0042
14. Klok FA, Kruip M, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. Apr 10 2020;doi:10.1016/j.thromres.2020.04.013
15. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. May 2020;18(5):1094-1099. doi:10.1111/jth.14817
16. Pan D, Sze S, Minhas JS, et al. The impact of ethnicity on clinical outcomes in COVID-19: A systematic review. EClinicalMedicine. Jun 2020;23:100404. doi:10.1016/j.eclinm.2020.100404
17. Rentsch CT, Kidwai-Khan F, Tate JP, et al. Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans. medRxiv. May 2020;doi:10.1101/2020.05.12.20099135
18. Morrone KA, Strumph K, Liszewski MC, et al. Acute chest syndrome in the setting of SARS‐COV‐2 infections—A case series at an urban medical center in the Bronx. Pediatric Blood & Cancer. 2020;67(11):e28579. doi:10.1002/pbc.28579
19. Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. Apr 22 2020;doi:10.1111/jth.14869
20. Avruscio G, Camporese G, Campello E, et al. COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward. Clin Transl Sci. Nov 2020;13(6):1108-1114. doi:10.1111/cts.12907
21. Sun Y, Dong Y, Wang L, et al. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J Autoimmun. Aug 2020;112:102473. doi:10.1016/j.jaut.2020.102473
22. Nutescu EA, Spinler SA, Wittkowsky A, Dager WE. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings. Ann Pharmacother. Jun 2009;43(6):1064-83. doi:10.1345/aph.1L194
23. Cuker A. ASH 2020 guidelines on the use of anticoagulation in patients with COVID-19: Draft recommendations.
24. Goldenberg NA, Sochet A, Albisetti M, et al. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness. J Thromb Haemost. Nov 2020;18(11):3099-3105. doi:10.1111/jth.15073